Your browser doesn't support javascript.
loading
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease.
Turner, Raymond S; Hebron, Michaeline L; Lawler, Abigail; Mundel, Elizabeth E; Yusuf, Nadia; Starr, J Nathan; Anjum, Muhammad; Pagan, Fernando; Torres-Yaghi, Yasar; Shi, Wangke; Mulki, Sanjana; Ferrante, Dalila; Matar, Sara; Liu, Xiaoguang; Esposito, Giuseppe; Berkowitz, Frank; Jiang, Xiong; Ahn, Jaeil; Moussa, Charbel.
  • Turner RS; Memory Disorders Program, Department of Neurology, Georgetown University Medical Center, Washington, DC, USA.
  • Hebron ML; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Washington, DC, USA.
  • Lawler A; Movement Disorders Clinic, Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Mundel EE; Movement Disorders Clinic, Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Yusuf N; Movement Disorders Clinic, Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Starr JN; Movement Disorders Clinic, Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Anjum M; Movement Disorders Clinic, Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Pagan F; Movement Disorders Clinic, Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Torres-Yaghi Y; Movement Disorders Clinic, Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Shi W; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Washington, DC, USA.
  • Mulki S; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Washington, DC, USA.
  • Ferrante D; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Washington, DC, USA.
  • Matar S; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Washington, DC, USA.
  • Liu X; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Washington, DC, USA.
  • Esposito G; Division of Nuclear Medicine, Washington, DC, USA.
  • Berkowitz F; Department of Radiology, MedStar Georgetown Hospital, Washington, DC, USA.
  • Jiang X; Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA.
  • Ahn J; Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center, Washington, DC, USA.
  • Moussa C; Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Washington, DC, USA.
Ann Neurol ; 88(1): 183-194, 2020 07.
Article en En | MEDLINE | ID: mdl-32468646
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Encéfalo / Proteínas Tirosina Quinasas / Enfermedad de Alzheimer Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Encéfalo / Proteínas Tirosina Quinasas / Enfermedad de Alzheimer Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article